US2017114086A1PendingUtilityA1
2'- substituted carba-nucleoside analogs for antiviral treatment
Est. expiryMar 13, 2032(~5.6 yrs left)· nominal 20-yr term from priority
Inventors:Michael O' Neil Hanrahan Clarke
A61P 31/14A61P 31/16A61P 43/00A61P 31/00A61K 31/706C07H 19/23A61K 45/06C07H 19/12A61M 2202/30A61M 15/00C07D 487/04
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are compounds of Formula I, as well as pharmaceutical compositions containing compounds of Formula I and methods for treating Orthomyxoviridae virus infections by administering these compounds. The compounds, compositions, and methods provided are particularly useful for the treatment of Human Influenza virus infections.
Claims
exact text as granted — not AI-modified1 - 64 . (canceled)
65 . A compound of Formula III:
wherein:
R 8 is NH 2 , OMe, OCH 2 CH 3 or ═O; and
R 9 is NH 2 , H, or F;
or a pharmaceutically acceptable salt, solvate, or ester thereof.
66 . The compound of claim 65 selected from the group consisting of
or a pharmaceutically acceptable salt, solvate, or ester thereof.Join the waitlist — get patent alerts
Track US2017114086A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.